A one-week dosing regimen for Mentax has been approved for the treatment of athlete's foot. The dosing regimen allows topical application either twice-a-day for seven days, or once-a-day for four weeks for more severe cases of the fungus. Mentax is the only topical antifungal product approved in the U.S. which has such a one-week dosing regimen.
The Mentax (1% butenafine HCl cream) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.